Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain

This study has been completed.

Study NCT00410787 Information provided by Alza Corporation, DE, USA

First Received: December 12, 2006 Last Updated: July 10, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2002
Estimated Primary Completion Date:	No date given